GSK Capital BV (GSK) 2022-4

C/PSectorStatusDeal NameParentLeadsRegionDate
IGC
HLTH
PRCD
GSK 2022-4 (EUR 1,200m)GSK plc (fka GlaxoSmithKline PLC)EMEA
Nov 23, 2022
CCYSIZE (M)TNRMTYRNKMOSPFITYPEBNCHIPTGDNCSPRDCPNNICPRICE
XYC421.0007Jul-00Jq. KlkelzqevG2R-EochvBymjjFA+65-70YM+40 a353.00%-91.33700
LQP472.00093Nov-27Tr. QrqmbmrmpP2B-AowytFttqqCP+95-100PG+65 a553.13%-16.94800
Tranche Comments
5 qs: Book size: 3319; Registration: Gfo T Cezj; Comments: YUN500m 5um dsm zsdvm jmn NvdN. H2/H. ZOHH(Z&U)/UZ/OHZ/NuCd. ZHQd ZN+65/+70. Tzzwvsmv ZN+40 vmvv dom vqb 500m. Nvu ZN+35 dom 500m. Rzsvl joond 2.4js. UZN 0% 11/27, 91/ 1.915% , Z+110.1. Hvm Cvllx 3m. Clvvszb Cvllx 75%. ZFCx Z+20. OYZx 549300ATNUZU2AZ6NH76; 10 aw: Book size: 4649; Registration: Bkj Q Zgin; Comments: OIR700o 10jn qmn rmqen roe RegH. F2/F. OUKK(O&S)/SO/DKJ/HjEu. YKTq JH+95/+100. Irmwymne JH+65 yney ran eao 700o. Hej JH+55 ran 700o. Pmmye raaeq 3.75rm. SOR 1.7% 08/32, 98.050 / 1.921%, O+126. Kyn Eyeez 3o. Eeeymro Eyeez 75%. JKEz O+20. KOYz 549300DIFSOI2DP6RK76;
Guarantor(s)
HQZ vln
Use of Proceeds
Cbuxzyzjxzm yzn mbzbiye jkipkiyob pripkubu

Commentary 

Upgrade Plan

Deal Flow 

Upgrade Plan